Potential role for statins in the treatment of chronic HCV infection

被引：4
|
作者：
Zhu, Qianqian [1 ]
Han, Qunying [1 ]
Liu, Zhengwen [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Xian 710061, Shaanxi Provinc, Peoples R China
来源：
FUTURE VIROLOGY | 2013年 / 8卷 / 08期
关键词：
chronic hepatitis C; direct-acting antiviral; host-targeting agent; IFN-; ribavirin; statin; treatment; CHRONIC HEPATITIS-C; VIRUS-RNA REPLICATION; PEGYLATED INTERFERON; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; GENOTYPE; 1B; OPEN-LABEL; FLUVASTATIN; RESISTANCE;
D O I：
10.2217/fvl.13.70
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：727 / 729
页数：3
相关论文
共 50 条
  • [21] Commentary on Treatment of HCV infection in chronic kidney disease
    Alavian, S. M.
    NEFROLOGIA, 2011, 31 (05): : 607 - 607
  • [22] A new standard of care for the treatment of chronic HCV infection
    Wolf Peter Hofmann
    Stefan Zeuzem
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 : 257 - 264
  • [23] Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
    Coppola, N.
    Marrone, A.
    Pisaturo, M.
    Starace, M.
    Signoriello, G.
    Gentile, I.
    Adinolfi, L. E.
    Sagnelli, E.
    Zampino, R.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (04) : 559 - 567
  • [24] Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
    N. Coppola
    A. Marrone
    M. Pisaturo
    M. Starace
    G. Signoriello
    I. Gentile
    L. E. Adinolfi
    E. Sagnelli
    R. Zampino
    European Journal of Clinical Microbiology & Infectious Diseases, 2014, 33 : 559 - 567
  • [25] Fibromyalgia syndrome in chronic hepatitis C virus (HCV) infection patients: A potential association and pathogenic role
    Afifi, Abdel Moatty A.
    Elzulaky, Dina W.
    Ahmed, Nancy A.
    Sallam, Rehab A.
    EGYPTIAN RHEUMATOLOGIST, 2022, 44 (01): : 87 - 90
  • [26] Treatment adherence and post treatment follow up for treatment of chronic HCV infection
    Wallace, M.
    Kong, J.
    Nazareth, S.
    Mcinerney, M.
    Tarquinio, L.
    Flexman, J.
    Cheng, W.
    Kontorinis, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A130 - A130
  • [27] The role of hypoadiponectinemia in hepatic steatosis associated with chronic HCV infection
    Bessa, S.
    Elwan, N.
    Baalash, A.
    Hamooda, H.
    Kamal, H.
    LIVER INTERNATIONAL, 2006, 26 : 84 - 84
  • [28] THE ROLE OF CELLULAR IMMUNE-RESPONSE IN CHRONIC HCV INFECTION
    LOHR, HF
    SCHLAAK, JF
    KOLLMANNSPERGER, S
    DIENES, HP
    ZUMBUSCHENFELDE, KHM
    HEPATOLOGY, 1994, 20 (04) : A230 - A230
  • [29] The role of hypoadiponectinemia in hepatic steatosis associated with chronic HCV infection
    Bessa, S.
    Elwan, N.
    Hamooda, H.
    Baalash, A.
    Kamal, H.
    LIVER INTERNATIONAL, 2006, 26 : 101 - 101
  • [30] Statins could have a potential role in the treatment of the influenza virus
    Attwood, Claire
    FUTURE VIROLOGY, 2012, 7 (02) : 124 - 124
12345